|
Unlike most pharmaceutical companies, Abamont is positioned to handle human niche therapeutics that are essential for small groups of patients, that are prescribed by
specialized medical practitioners and often used to treat rare diseases.
These products are important to the patients and their
doctors, but they often fall outside of the focus of the larger companies due to their large operations, economies of scale and commercial considerations. |